This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huang, Z.-y.
Right arrow Articles by Gutmann, D. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huang, Z.-y.
Right arrow Articles by Gutmann, D. H.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, January 2003, p. 566-578, Vol. 23, No. 2
0270-7306/03/$08.00+0     DOI: 10.1128/MCB.23.2.566-578.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

T-Cadherin-Mediated Cell Growth Regulation Involves G2 Phase Arrest and Requires p21CIP1/WAF1 Expression

Zhi-yong Huang, YanLi Wu, Nicolé Hedrick, and David H. Gutmann*

Department of Neurology, Washington University School of Medicine, St. Louis, Missouri

Received 29 July 2002/ Returned for modification 7 October 2002/ Accepted 17 October 2002

Members of the cadherin family have been implicated as growth regulators in multiple tumor types. Based on recent studies from our laboratory implicating T-cadherin expression in mouse brain tumorigenesis, we examined the role of T-cadherin in astrocytoma growth regulation. In this report, we show that T-cadherin expression increased during primary astrocyte physiologic growth arrest in response to contact inhibition and serum starvation in vitro, suggesting a function for T-cadherin in astrocyte growth regulation. We further demonstrate that transient and stable reexpression of T-cadherin in deficient C6 glioma cell lines results in growth suppression. In addition, T-cadherin-expressing C6 cell lines demonstrated increased homophilic cell aggregation, increased cell attachment to fibronectin, and decreased cell motility. Cell cycle flow cytometry demonstrated that T-cadherin reexpression resulted in G2 phase arrest, which was confirmed by mitotic index analysis. This growth arrest was p53 independent, as T-cadherin could still mediate growth suppression in p53-/- mouse embryonic fibroblasts. T-cadherin-expressing C6 cell lines exhibited increased p21CIP1/WAF1, but not p27Kip1, expression. Lastly, T-cadherin-mediated growth arrest was dependent on p21CIP1/WAF1 expression and was eliminated in p21CIP1/WAF1-deficient fibroblasts. Collectively, these observations suggest a novel mechanism of growth regulation for T-cadherin involving p21CIP1/WAF1 expression and G2 arrest.


* Corresponding author. Mailing address: Department of Neurology, Washington University School of Medicine, Box 8111; 660 S. Euclid Ave., St. Louis, MO 63110. Phone: (314) 362-7379. Fax: (314) 362-2388. E-mail: gutmannd{at}neuro.wustl.edu.


Molecular and Cellular Biology, January 2003, p. 566-578, Vol. 23, No. 2
0022-538X/03/$08.00+0     DOI: 10.1128/MCB.23.2.566-578.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Andreeva, A. V., Kutuzov, M. A., Tkachuk, V. A., Voyno-Yasenetskaya, T. A. (2009). T-cadherin is located in the nucleus and centrosomes in endothelial cells. Am. J. Physiol. Cell Physiol. 297: C1168-C1177 [Abstract] [Full Text]  
  • Hebbard, L. W., Garlatti, M., Young, L. J.T., Cardiff, R. D., Oshima, R. G., Ranscht, B. (2008). T-cadherin Supports Angiogenesis and Adiponectin Association with the Vasculature in a Mouse Mammary Tumor Model. Cancer Res. 68: 1407-1416 [Abstract] [Full Text]  
  • Ouellet, S., Vigneault, F., Lessard, M., Leclerc, S., Drouin, R., Guerin, S. L. (2006). Transcriptional regulation of the cyclin-dependent kinase inhibitor 1A (p21) gene by NFI in proliferating human cells. Nucleic Acids Res 34: 6472-6487 [Abstract] [Full Text]  
  • Li, Y., Mao, Y., Brandt-Rauf, P. W., Williams, A. C., Fine, R. L. (2005). Selective induction of apoptosis in mutant p53 premalignant and malignant cancer cells by PRIMA-1 through the c-Jun-NH2-kinase pathway. Molecular Cancer Therapeutics 4: 901-909 [Abstract] [Full Text]  
  • Ivanov, D., Philippova, M., Allenspach, R., Erne, P., Resink, T. (2004). T-cadherin upregulation correlates with cell-cycle progression and promotes proliferation of vascular cells. Cardiovasc Res 64: 132-143 [Abstract] [Full Text]  
  • Hug, C., Wang, J., Ahmad, N. S., Bogan, J. S., Tsao, T.-S., Lodish, H. F. (2004). T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin. Proc. Natl. Acad. Sci. USA 101: 10308-10313 [Abstract] [Full Text]  
  • Gurok, U., Steinhoff, C., Lipkowitz, B., Ropers, H.-H., Scharff, C., Nuber, U. A. (2004). Gene Expression Changes in the Course of Neural Progenitor Cell Differentiation. J. Neurosci. 24: 5982-6002 [Abstract] [Full Text]